Rapid Micro Biosystems Toekomstige groei
Future criteriumcontroles 1/6
Rapid Micro Biosystems is forecast to grow revenue at 19.7% per annum. EPS is expected to grow by 18.7% per annum.
Belangrijke informatie
n/a
Groei van de winst
18.7%
Groei van de winst per aandeel
Life Sciences winstgroei | 18.4% |
Inkomstengroei | 19.7% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 01 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story
Nov 02Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?
Oct 29A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb
Aug 03We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Jun 30Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing
Oct 10Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth
May 09Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67
Mar 08We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Feb 07Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 33 | N/A | N/A | N/A | 2 |
12/31/2024 | 27 | -46 | N/A | N/A | 2 |
9/30/2024 | 26 | -48 | N/A | N/A | N/A |
6/30/2024 | 25 | -50 | -47 | -45 | N/A |
3/31/2024 | 23 | -52 | -46 | -44 | N/A |
12/31/2023 | 23 | -52 | -47 | -45 | N/A |
9/30/2023 | 21 | -58 | -49 | -47 | N/A |
6/30/2023 | 19 | -61 | -56 | -53 | N/A |
3/31/2023 | 18 | -60 | -64 | -58 | N/A |
12/31/2022 | 17 | -61 | -65 | -59 | N/A |
9/30/2022 | 18 | -59 | -68 | -60 | N/A |
6/30/2022 | 20 | -68 | -71 | -64 | N/A |
3/31/2022 | 22 | -69 | -66 | -61 | N/A |
12/31/2021 | 23 | -78 | -58 | -55 | N/A |
9/30/2021 | 23 | -77 | -49 | -47 | N/A |
6/30/2021 | 22 | -63 | -38 | -37 | N/A |
3/31/2021 | 18 | -60 | -35 | -34 | N/A |
12/31/2020 | 16 | -45 | -32 | -31 | N/A |
12/31/2019 | 17 | -27 | -23 | -21 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if RPID's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if RPID's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if RPID's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: RPID's revenue (19.7% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: RPID's revenue (19.7% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if RPID's Return on Equity is forecast to be high in 3 years time